These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 11738543)

  • 1. Cerebral blood flow in obsessive-compulsive patients with major depression: effect of treatment with sertraline or desipramine on treatment responders and non-responders.
    Hoehn-Saric R; Schlaepfer TE; Greenberg BD; McLeod DR; Pearlson GD; Wong SH
    Psychiatry Res; 2001 Nov; 108(2):89-100. PubMed ID: 11738543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional cerebral blood flow in obsessive-compulsive disordered patients at rest. Differential correlates with obsessive-compulsive and anxious-avoidant dimensions.
    Lucey JV; Costa DC; Blanes T; Busatto GF; Pilowsky LS; Takei N; Marks IM; Ell PJ; Kerwin RW
    Br J Psychiatry; 1995 Nov; 167(5):629-34. PubMed ID: 8564319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated thalamic and prefrontal regional cerebral blood flow in obsessive-compulsive disorder: a SPECT study.
    Lacerda AL; Dalgalarrondo P; Caetano D; Camargo EE; Etchebehere EC; Soares JC
    Psychiatry Res; 2003 Jun; 123(2):125-34. PubMed ID: 12850251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain reactivity to specific symptom provocation indicates prospective therapeutic outcome in OCD.
    Hendler T; Goshen E; Tzila Zwas S; Sasson Y; Gal G; Zohar J
    Psychiatry Res; 2003 Oct; 124(2):87-103. PubMed ID: 14561427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional 133xenon cerebral blood flow and cerebral 99mTc-HMPAO uptake in patients with obsessive-compulsive disorder before and during treatment.
    Rubin RT; Ananth J; Villanueva-Meyer J; Trajmar PG; Mena I
    Biol Psychiatry; 1995 Oct; 38(7):429-37. PubMed ID: 8672603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicenter double-blind comparison of sertraline and desipramine for concurrent obsessive-compulsive and major depressive disorders.
    Hoehn-Saric R; Ninan P; Black DW; Stahl S; Greist JH; Lydiard B; McElroy S; Zajecka J; Chapman D; Clary C; Harrison W
    Arch Gen Psychiatry; 2000 Jan; 57(1):76-82. PubMed ID: 10632236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The value of HMPAO SPECT in predicting treatment response to citalopram in patients with major depression.
    Brockmann H; Zobel A; Joe A; Biermann K; Scheef L; Schuhmacher A; von Widdern O; Metten M; Biersack HJ; Maier W; Boecker H
    Psychiatry Res; 2009 Aug; 173(2):107-12. PubMed ID: 19540732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Right basal ganglion hypoperfusion in obsessive compulsive disorder patients demonstrated by Tc-99m-HMPAO brain perfusion spect: a controlled study.
    Topçuoglu V; Cömert B; Karabekiroglu A; Dede F; Erdil TY; Turoglu HT
    Int J Neurosci; 2005 Dec; 115(12):1643-55. PubMed ID: 16287631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacotherapy and regional cerebral blood flow in children with obsessive compulsive disorder.
    Diler RS; Kibar M; Avci A
    Yonsei Med J; 2004 Feb; 45(1):90-9. PubMed ID: 15004874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional cerebral blood flow abnormalities in early-onset obsessive-compulsive disorder: an exploratory SPECT study.
    Busatto GF; Buchpiguel CA; Zamignani DR; Garrido GE; Glabus MF; Rosario-Campos MC; Castro CC; Maia A; Rocha ET; McGuire PK; Miguel EC
    J Am Acad Child Adolesc Psychiatry; 2001 Mar; 40(3):347-54. PubMed ID: 11288777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes after behavior therapy among responsive and nonresponsive patients with obsessive-compulsive disorder.
    Yamanishi T; Nakaaki S; Omori IM; Hashimoto N; Shinagawa Y; Hongo J; Horikoshi M; Tohyama J; Akechi T; Soma T; Iidaka T; Furukawa TA
    Psychiatry Res; 2009 Jun; 172(3):242-50. PubMed ID: 19346109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional xenon 133 cerebral blood flow and cerebral technetium 99m HMPAO uptake in unmedicated patients with obsessive-compulsive disorder and matched normal control subjects. Determination by high-resolution single-photon emission computed tomography.
    Rubin RT; Villanueva-Meyer J; Ananth J; Trajmar PG; Mena I
    Arch Gen Psychiatry; 1992 Sep; 49(9):695-702. PubMed ID: 1514874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single photon emission computed tomography (SPECT) of anxiety disorders before and after treatment with citalopram.
    Carey PD; Warwick J; Niehaus DJ; van der Linden G; van Heerden BB; Harvey BH; Seedat S; Stein DJ
    BMC Psychiatry; 2004 Oct; 4():30. PubMed ID: 15482603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in regional cerebral blood flow following antidepressant treatment in late-life depression.
    Ishizaki J; Yamamoto H; Takahashi T; Takeda M; Yano M; Mimura M
    Int J Geriatr Psychiatry; 2008 Aug; 23(8):805-11. PubMed ID: 18214999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased thalamic blood flow in obsessive-compulsive disorder patients responding to fluvoxamine.
    Ho Pian KL; van Megen HJ; Ramsey NF; Mandl R; van Rijk PP; Wynne HJ; Westenberg HG
    Psychiatry Res; 2005 Feb; 138(2):89-97. PubMed ID: 15766633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The comparison of pre- and post-treatment (99m)Tc HMPAO brain SPECT images in patients with obsessive-compulsive disorder.
    Karadağ F; Kalkan Oğuzhanoğlu N; Yüksel D; Kıraç S; Cura C; Ozdel O; Ateşci F
    Psychiatry Res; 2013 Aug; 213(2):169-77. PubMed ID: 23149026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opposite effects of high and low frequency rTMS on regional brain activity in depressed patients.
    Speer AM; Kimbrell TA; Wassermann EM; D Repella J; Willis MW; Herscovitch P; Post RM
    Biol Psychiatry; 2000 Dec; 48(12):1133-41. PubMed ID: 11137053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional cerebral blood flow changes after low-frequency transcranial magnetic stimulation of the right dorsolateral prefrontal cortex in treatment-resistant depression.
    Kito S; Fujita K; Koga Y
    Neuropsychobiology; 2008; 58(1):29-36. PubMed ID: 18781088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential cerebral metabolic changes with paroxetine treatment of obsessive-compulsive disorder vs major depression.
    Saxena S; Brody AL; Ho ML; Alborzian S; Maidment KM; Zohrabi N; Ho MK; Huang SC; Wu HM; Baxter LR
    Arch Gen Psychiatry; 2002 Mar; 59(3):250-61. PubMed ID: 11879163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional cerebral blood flow abnormalities in late-life depression: relation to refractoriness and chronification.
    Awata S; Ito H; Konno M; Ono S; Kawashima R; Fukuda H; Sato M
    Psychiatry Clin Neurosci; 1998 Feb; 52(1):97-105. PubMed ID: 9682941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.